A 12-week, randomized, parallel-group, proof-of-concept study of tulobuterol patch and salmeterol inhaler as add-on therapy in adult-onset mild-to-moderate asthma
Author:
Affiliation:
1. Department of Respiratory Medicine; Graduate School of Medicine; Kyoto University; Kyoto Japan
2. Department of Respiratory Medicine; Allergy and Clinical Immunology; Graduate School of Medical Sciences; Nagoya City University; Nagoya Aichi Japan
Publisher
Wiley
Subject
Physiology (medical),Pharmacology,Physiology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/1440-1681.12683/fullpdf
Reference34 articles.
1. Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids;Barnes;Eur Respir J,2002
2. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group;Greening;Lancet,1994
3. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids;Woolcock;Am J Respir Crit Care Med,1996
4. The pharmacokinetics of the beta 2-adrenoceptor agonist, tulobuterol, given transdermally and by inhalation;Uematsu;Eur J Clin Pharmacol,1993
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effect of Tulobuterol Patch Versus Placebo on the Occurrence of Respiratory Adverse Events in Children Undergoing Tonsillectomies: A Randomized Controlled Trial;Anesthesia & Analgesia;2023-05-19
2. Asthma and COPD: A Focus on β-Agonists – Past, Present and Future;Handbook of Experimental Pharmacology;2023
3. Small airways in asthma: from bench-to-bedside;Minerva Medica;2022-03
4. Comparison of 12-Week Additional Effect Features of Formoterol Co-Inhalation and Tulobuterol Patch on Budesonide Inhalation in Elderly Patients With Asthma;Allergy & Rhinology;2020-01
5. Late-onset asthma: current perspectives;Journal of Asthma and Allergy;2018-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3